Schedule 13D ownership disclosure
EAGLE PHARMACEUTICALS INC
Security class unavailable · CUSIP: 269796108
Event date: 2016-06-15
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 6.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000945621-16-000639
- Form type
- SC 13D
- Filer
- EAGLE PHARMACEUTICALS, INC.
- CIK
- CIK 827871
- Filed
- Jun 27, 2016
- Reporting period
- Jun 15, 2016
- Description
- Schedule 13D beneficial ownership